Blog
Cerebras Soared 68% in Its First Day of Trading. After This Explosive IPO, Is It Too Late to Buy the Stock?
Artificial intelligence (AI) stocks have driven the S&P 500 during this three-year-plus bull market as investors rushed to get in on a game-changing story. This technology, with its potential to
Nvidia vs. Alphabet: Which Will Be the World's Biggest Company By the End of 2026?
Only about a dozen companies have ever reached a $1 trillion valuation. Only one has gotten to $5 trillion: Nvidia (NASDAQ: NVDA). The chipmaker is in a league of its own and currently holds the
Too Many Retirees Withdraw Money the Wrong Way. Here's a Smarter Approach.
For many people, the hardest part of retirement planning begins after they stop working. Saving for retirement is one challenge. Figuring out how to turn those savings into lasting income is
Market Crash: The Financial Stocks I'd Buy Without Hesitation
Markets have been volatile each of the past two years, with investors experiencing at least a 10% correction followed by a strong rebound. Volatility remains a threat to markets as geopolitical
This Tech Stock Doesn't Need AI to Win. That's Exactly Why It's My Top Pick Right Now.
The artificial intelligence (AI) market has gone utterly ballistic over the past couple of years and demonstrated shocking resilience. No matter how many people have warned of the potential of an AI
Alfreton Capital Sees Opportunity in CCC, Buys 1.98M Shares
According to a SEC filing dated May 14, 2026, Alfreton Capital LLP increased its position in CCC Intelligent Solutions (NASDAQ:CCC) by 1,978,074 shares. The estimated value of these purchases was
Sea (SE) Q1 2026 Earnings Call Transcript
Image source: The Motley Fool.
Tuesday, May 12, 2026 at 7:30 a.m. ET
Need a quote from a Motley Fool analyst? Email [email protected]
Source Fool.com
Heron Bay Doubles Down on Vontier, Buying 1.37 Million Shares
According to a Securities and Exchange Commission (SEC) filing dated May 13, 2026, Heron Bay Capital Management acquired an additional 1,370,006 shares of Vontier (NYSE:VNT), during the first
Ares Capital's Dividend Looks Tempting. Here's What Investors Need to Check Now
The main attraction for most investors in Ares Capital (NASDAQ: ARCC) will likely be the stock's high 10% yield. For comparison, the S&P 500 index (SNPINDEX: ^GSPC) is currently yielding around
2 Recession-Resistant Dividend Stocks to Buy Now While They're Still Cheap
The popular clickbait framing of "recession-resistant" stocks often points to consumer staples and utilities. That is not wrong, but it skips two of the more durable and boring cash-flow profiles in
This Nuclear Tech Stock Grew Revenue 27%, But a Fund Still Slashed Its Stake
Nicholas Investment Partners disclosed in a May 15, 2026, SEC filing that it sold 592,382 shares of Mirion Technologies (NYSE:MIR), an estimated $13.36 million trade based on quarterly average
The Best Energy Stock to Invest $10,000 in Right Now
The best way to take advantage of high oil and natural prices is to buy a company that produces these vital fuels. A U.S. producer like Devon Energy (NYSE: DVN) would be a good option, since its
This Retail Stock Is Down 10% in a Year Despite Record Revenue. A Fund Just Cut Its Stake
On May 15, 2026, Nicholas Investment Partners disclosed selling 109,532 shares of Abercrombie & Fitch Co. (NYSE:ANF), an estimated $10.65 million trade based on quarterly average pricing.
According
Why Dogecoin Was a dog of an Investment on Friday
Dogecoin (CRYPTO: DOGE) couldn't be considered a good boy for investors late Friday afternoon. As of 4 p.m. ET, the leading meme coin was trading down by almost 3% amid negative sentiment affecting
This Trade School Stock Is Up 135%. Here’s Why a Fund Still Bought 459,000 Shares
Nicholas Investment Partners initiated a new position in Lincoln Educational Services Corporation (NASDAQ:LINC) in its May 15, 2026, SEC filing, acquiring 459,509 shares in an estimated $14.46
Callaway Stock Has Soared 150%. Here’s Why One Fund Still Bought 1.1 Million Shares
On May 15, 2026, Nicholas Investment Partners, LP disclosed a new position in Callaway Golf Company (NYSE:CALY), acquiring 1,125,984 shares in an estimated $15.80 million trade based on quarterly
Why Bitcoin Was Slumping on Friday
The world's leading cryptocurrency didn't look like much of a leader as we headed into the weekend. From 4 p.m. ET on Friday, Bitcoin (CRYPTO: BTC) was sliding by nearly 3% in late afternoon
Prediction: This Stock Could Double By 2031
Exelixis (NASDAQ: EXEL) has been a solid stock to own over the past five years, with its shares climbing 101%, slightly beating out the S&P 500. The good news is that there is plenty of upside left
Starbucks is Set to Lay Off 300 Corporate Employees as Part of Its Turnaround Strategy
Starbucks (NASDAQ: SBUX) brought in former Chipotle CEO Brian Niccol to turn around the struggling coffee chain, and nearly two years later, his effort seems to be bearing fruit.
Comparable sales
TJX Companies: A Retail Powerhouse Poised for Growth
Explore the exciting world of The TJX Companies (NYSE: TJX) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into
Why KinderCare Learning Stock Flopped on Friday
Friday was not a good school day for early education and child care services provider KinderCare Learning (NYSE: KLC). The company published first-quarter results that slightly beat analyst
Poet Technologies Sank Today -- Is The Stock a Buy Right Now?
After surging roughly 43% in yesterday's trading, Poet Technologies (NASDAQ: POET) stock got hit with a big pullback on Friday. The company's share price fell 22.4% in a day of trading that saw the
Bicara Stock Is Up 50%, and One Biotech Investor Has Made It a 29% Portfolio Bet
Omega Fund Management disclosed a buy of 187,500 shares of Bicara Therapeutics (NASDAQ:BCAX) in a May 15, 2026, SEC filing, with the estimated transaction value at $3.23 million based on quarterly
Alumis Stock Is Up Over 300%. One Major Healthcare Investor Is Cutting Back
On May 15, 2026, Omega Fund Management disclosed in an SEC filing that it sold 411,968 shares of Alumis (NASDAQ:ALMS), with the estimated transaction value at $10.3 million based on quarterly
Kestra Medical Grew Revenue 63%. One Fund Still Trimmed 351,000 Shares
Omega Fund Management cut its stake in Kestra Medical Technologies (NASDAQ:KMTS), selling 351,442 shares in the first quarter for an estimated $8.28 million based on quarterly average pricing